ArticlePharmaceuticals (Basel, Switzerland)2026
Therapeutic Effects of Combined 6-Shogaol and Ibudilast on Neuroinflammation and Behavioral Deficits in a Cuprizone Mouse Model of Multiple Sclerosis.
Gadah Ali Alshahrany, Kholoud A Alyami, Noor Ahmed Alzahrani, Mohammad Zubair Alam, Badrah S Alghamdi, Ulfat M Omar, Abeer A Banjabi, Huda F Alshaibi, Rana Jamalaldin Jambi, Kholoud M Al-Otaibi and 1 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Gadah Ali AlshahranyDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0001-7493-7224 Kholoud A AlyamiDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Noor Ahmed AlzahraniDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Mohammad Zubair AlamNeuroscience and Geroscience Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-2843-169X Badrah S AlghamdiNeuroscience and Geroscience Research Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Ulfat M OmarDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-9751-8476 Abeer A BanjabiDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Huda F AlshaibiDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0003-3739-8844 Rana Jamalaldin JambiThe Applied College, Department of Health Information Technology, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Kholoud M Al-OtaibiDepartment of Chemistry, Faculty of Science, Al-Baha University, Al-Baha 65799, Saudi Arabia.ORCID 0000-0002-8104-5862 Hadeil M AlsufianiDepartment of Biochemistry, Faculty of Sciences, King Abdulaziz University, Jeddah 21589, Saudi Arabia.ORCID 0000-0002-8474-8985 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
6-shogaolcombination therapycuprizoneibudilastmultiple sclerosisnatural productsneuroinflammation
Identifiers
PMID42515688
PMCPMC13415178
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390